<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Pi-Cardia 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=36767></link><description><![CDATA[Pi-Cardia 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Mon, 18 May 2026 20:00:27 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2021/01/12_3554238800_20210106145056_9972950977.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Pi-Cardia Successfully Treats First Patients with ShortCut™ Device]]></title><link>https://www.newswire.co.kr/newsRead.php?no=916882</link><description><![CDATA[REHOVOT, Israel--(Business Wire/Korea Newswire)--Pi-Cardia Ltd., a global leader in the development of non-implant, catheter-based solutions for treating heart valves, announced today successful first-in-human procedures with its ShortCut™ device. ShortCut™ is the world’s first dedicated device designed to split the leaflets of a pre-existing valve to enable safe Transcatheter Aortic Valve Rep...]]></description><pubDate>Fri, 08 Jan 2021 01:00:00 +0900</pubDate></item><item><title><![CDATA[Pi-카디아, 숏컷으로 심장 판막 환자 첫 치료 성공]]></title><link>https://www.newswire.co.kr/newsRead.php?no=916883</link><description><![CDATA[레호보트, 이스라엘--(Business Wire/뉴스와이어)--심장 판막 치료용 비임플란트(non-implant) 카테터 기반 솔루션 개발업계를 선도하는 Pi-카디아(Pi-Cardia Ltd.)가 숏컷(ShortCut™) 기기로 FIH(first-in-human) 치료에 성공했다고 5일 발표했다.  숏컷은 관상 동맥 접근으로 인한 면역 손상이나 관상 동맥 폐쇄 위험이 높은 환자에게 안전한 경피적대동맥판막치환술(TAVR)을 수행할 수 있도록 돕는 세계 최초 판막엽 분리 ...]]></description><pubDate>Fri, 08 Jan 2021 01:00:00 +0900</pubDate></item></channel></rss>